NASDAQ:NRBO
NeuroBo Pharmaceuticals, Inc. Stock News
$4.13
+0.155 (+3.90%)
At Close: May 24, 2024
NeuroBo Pharmaceuticals Submits IND Application to the FDA for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity
08:45am, Thursday, 28'th Dec 2023
CAMBRIDGE, Mass. , Dec. 28, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced
NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split
08:43am, Tuesday, 19'th Dec 2023
Commencement of Trading on Split-Adjusted Basis on December 21, 2023 BOSTON , Dec. 19, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused
NeuroBo to Participate in Investor Conferences in December
08:31am, Friday, 01'st Dec 2023
BOSTON , Dec. 1, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced
NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
04:05pm, Monday, 13'th Nov 2023
DA-1726 Phase 1 IND Filing Expected by Year End 2023 Board Strengthened with Recent Appointment of Industry Veteran, James P. Tursi, M.D.
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
08:05am, Monday, 06'th Nov 2023
BOSTON , Nov. 6, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appoint
NeuroBo to Present at the H.C. Wainwright 7th Annual NASH Investor Conference
08:01am, Tuesday, 17'th Oct 2023
BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced that Hyu
4 Undervalued Medical Stocks to Buy Amid High Market Volatility
09:46am, Friday, 29'th Sep 2023
Amid volatility, undervalued companies with solid prospects cushion investors from market jitters, while their robust fundamentals ensure higher returns. ACHC, PGNY, EGRX and NRBO are four such stocks
Want to Shrug Off Volatility? Buy 3 Medical Growth Stocks
09:01am, Thursday, 28'th Sep 2023
We pick three medical stocks - MOH, RDY and NRBO - that have gained more than 5% in the past three months amid market volatility.
10 Top Penny Stocks To Watch Right Now For Under $1
01:20pm, Thursday, 29'th Jun 2023
Welcome to the world of penny stocks. This is a corner of the stock market that piques interest and raises eyebrows in equal measure.
7 Penny Stocks To Watch Right Now For Under $1
03:37pm, Tuesday, 27'th Jun 2023
Have you ever dreamt of uncovering a hidden gem in the stock market, something that could turn your modest investment into a jackpot? Welcome to the world of penny stocks.
Here's Why NeuroBo Pharmaceuticals, Inc. (NRBO) Could be Great Choice for a Bottom Fisher
10:59am, Tuesday, 06'th Jun 2023
NeuroBo Pharmaceuticals, Inc. (NRBO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong
Penny Stocks To Buy? 10 Under $1 To Watch This Week
03:29pm, Wednesday, 19'th Apr 2023
Penny stocks under $1 to watch this week. The post Penny Stocks To Buy?
Penny Stocks To Buy? 7 Under $1 To Watch This Week
11:15am, Monday, 17'th Apr 2023
Penny stocks to watch trading for pennies this week. The post Penny Stocks To Buy?
Best Penny Stocks To Buy Before 2023? 4 To Watch Now
09:54am, Friday, 30'th Dec 2022
Penny stocks to watch this week with news before 2023. The post Best Penny Stocks To Buy Before 2023?
How to Manage Risk When Investing in Penny Stocks
06:02am, Monday, 12'th Dec 2022
Consider these factors for investing in penny stocks The post How to Manage Risk When Investing in Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.